FLT3 and acute myeloid leukemia: All levels of FLT3–ITD ARs (four levels) influenced the outcome of patients with AML in terms of poor OS and RFS; however, we did not detect significant differences concerning CR, RD, early death, or disease relapse (Table 3a).